New DELIVER guidelines aim to accelerate nanomedicine development

They’re tiny drug-delivery systems 1000 times smaller than a human hair, but while nanomedicines have long been hailed as the future for treating debilitating and life-threatening diseases, their journey from lab to patient has many challenges.

Medartis increases sales by 21% (CER) and improves its underlying EBITDA margin to 16% – Biotech Investments

Medartis Holding AG / Key word(s): Annual Results 12-March-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer

March 13, 2024

Eiger BioPharmaceuticals to focus on GLP-1 candidate, cut workforce by 25%

Eiger BioPharmaceuticals said it’s now focused on developing a GLP-1 antagonist amid a review of its business that includes laying off 25% of its employees

June 30, 2023

‘Bigger, faster, better’: Isomorphic, DeepMind unveil AlphaFold 3, going beyond protein predictions

Google DeepMind and Isomorphic Labs unveiled the newest version of AlphaFold, taking its flagship AI model far beyond predicting the structure of a single protein.

May 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.